Geode Capital Management
FENC icon

Geode Capital Management’s Fennec Pharmaceuticals FENC Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$2.53M Sell
304,597
-6,735
-2% -$55.9K ﹤0.01% 3063
2025
Q1
$1.9M Buy
311,332
+8,242
+3% +$50.2K ﹤0.01% 3054
2024
Q4
$1.92M Buy
303,090
+3,792
+1% +$24K ﹤0.01% 3144
2024
Q3
$1.5M Sell
299,298
-2,280
-0.8% -$11.4K ﹤0.01% 3213
2024
Q2
$1.84M Buy
301,578
+81,824
+37% +$500K ﹤0.01% 3145
2024
Q1
$2.44M Buy
219,754
+1,164
+0.5% +$12.9K ﹤0.01% 3041
2023
Q4
$2.45M Buy
218,590
+12,391
+6% +$139K ﹤0.01% 3026
2023
Q3
$1.55M Buy
206,199
+9,322
+5% +$70K ﹤0.01% 3166
2023
Q2
$1.74M Buy
196,877
+177,370
+909% +$1.57M ﹤0.01% 3156
2023
Q1
$162K Hold
19,507
﹤0.01% 4145
2022
Q4
$187K Hold
19,507
﹤0.01% 4139
2022
Q3
$158K Hold
19,507
﹤0.01% 4340
2022
Q2
$110K Hold
19,507
﹤0.01% 4553
2022
Q1
$109K Sell
19,507
-112
-0.6% -$626 ﹤0.01% 4628
2021
Q4
$86K Sell
19,619
-290
-1% -$1.27K ﹤0.01% 4767
2021
Q3
$187K Buy
19,909
+1,983
+11% +$18.6K ﹤0.01% 4477
2021
Q2
$130K Sell
17,926
-151,430
-89% -$1.1M ﹤0.01% 4488
2021
Q1
$1.05M Buy
169,356
+1,513
+0.9% +$9.39K ﹤0.01% 3538
2020
Q4
$1.25M Buy
167,843
+12,056
+8% +$89.8K ﹤0.01% 3294
2020
Q3
$944K Buy
155,787
+5,587
+4% +$33.9K ﹤0.01% 3236
2020
Q2
$1.25M Buy
+150,200
New +$1.25M ﹤0.01% 3073
2019
Q2
Sell
-46,059
Closed -$223K 4223
2019
Q1
$223K Buy
46,059
+6,570
+17% +$31.8K ﹤0.01% 3704
2018
Q4
$251K Buy
39,489
+5,441
+16% +$34.6K ﹤0.01% 3608
2018
Q3
$279K Buy
34,048
+4,799
+16% +$39.3K ﹤0.01% 3648
2018
Q2
$305K Buy
+29,249
New +$305K ﹤0.01% 3594